Article

$1.5 million gift launches GRF capital campaign

A gift of $1,550,000 has kicked off the Glaucoma Research Foundation's first year of a comprehensive new strategic plan.

San Francisco-A gift of $1,550,000 has kicked off the Glaucoma Research Foundation's (GRF) first year of a comprehensive new strategic plan, said Thomas M. Brunner, GRF president and chief executive officer. The gift from Melza and F.T. Barr supports the foundation's $12 million, 3-year capital campaign setting strategic imperatives through 2011.

"This is an extraordinary gift and sets an inspiring example that beating glaucoma must be everyone's top priority," Brunner said. "An epidemic of blindness from glaucoma may be coming if we don't act now to get ahead of this . . . disease. Following [this] wonderful lead, increased giving from all of us will enable GRF to fund the innovative research that gives genuine hope we will prevail."

F.T. Barr, a GRF board member from Houston, said, "I feel so strongly that GRF is on the right track, [that] I have increased my gift by 50% from our last capital campaign."

The foundation's first major gift program, the Catalyst Circle, was also born in that campaign, bringing in more than 100 donors at the $1,000 level and above.

Strategic imperatives in GRF's plan:

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.